Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Immermann

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Combinatorial Chemistry & High Throughput Screening|April 23, 2002
A novel approach to combinatorial library designRamaswamy Nilakantan, Fred Immermann, Kevin Haraki
Clinical Pharmacology and Therapeutics|January 8, 2005
Population pharmacokinetics of CCI-779: correlations to safety and pharmacogenomic responses in patients with advanced renal cancerJoseph P Boni, Cathie Leister, Gregor Bender, et al.
Biomarkers in Medicine|May 19, 2010
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxicsGrant Sellar, John D Alvarez, Frank Loganzo, et al.
Archives of Neurology|January 11, 2012
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutationsJohn M Ringman, Howard Schulman, Chris Becker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 4, 2017
The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical TrialsJoan T Merrill, Fred Immermann, Maryann Whitley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinomaMichael E Burczynski, Natalie C Twine, Gary Dukart, et al.
The Journal of Molecular Diagnostics : JMD|January 27, 2006
Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cellsMichael E Burczynski, Ron L Peterson, Natalie C Twine, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Combinatorial Chemistry & High Throughput Screening|April 23, 2002
A novel approach to combinatorial library designRamaswamy Nilakantan, Fred Immermann, Kevin Haraki
Clinical Pharmacology and Therapeutics|January 8, 2005
Population pharmacokinetics of CCI-779: correlations to safety and pharmacogenomic responses in patients with advanced renal cancerJoseph P Boni, Cathie Leister, Gregor Bender, et al.
Biomarkers in Medicine|May 19, 2010
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxicsGrant Sellar, John D Alvarez, Frank Loganzo, et al.
Archives of Neurology|January 11, 2012
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutationsJohn M Ringman, Howard Schulman, Chris Becker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 4, 2017
The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical TrialsJoan T Merrill, Fred Immermann, Maryann Whitley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinomaMichael E Burczynski, Natalie C Twine, Gary Dukart, et al.
The Journal of Molecular Diagnostics : JMD|January 27, 2006
Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cellsMichael E Burczynski, Ron L Peterson, Natalie C Twine, et al.
Pageof 1